Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Treating Mantle Cell Lymphoma: Role of BTK Inhibition
EP. 1: Understanding the Heterogeneity of Mantle Cell Lymphoma
January 18th 2019
EP. 2: Mantle Cell Lymphoma: Impact of Genetic Variants
January 18th 2019
EP. 3: Distinguishing MCL From Other Lymphomas
January 18th 2019
EP. 4: Mantle Cell Lymphoma: An Overview of Therapy
January 18th 2019
EP. 5: Optimizing Therapeutic Approaches to MCL
January 18th 2019
EP. 6: Selecting Therapy for Relapsed/Refractory MCL
January 18th 2019
EP. 7: Ibrutinib in MCL: Changing the Treatment Landscape
January 18th 2019
EP. 8: MCL: Long-Term Safety/Efficacy Data With Ibrutinib
January 18th 2019
EP. 9: Managing Adverse Events of Ibrutinib in Patients With MCL
January 18th 2019
EP. 10: Considering Off-Label Use of Ibrutinib in MCL
January 18th 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE